Investors

Founded in November 2012, ObsEva is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy. We believe our expertise has led to the development of new and innovative therapies that have the potential to improve patient outcomes in reproductive health.

Events

06 May 2019Week of May 6, 2019 – First Quarter 2019 Financial Results
05 Aug 2019Week of August 5, 2019 – Half Year 2019 Financial Results
04 Nov 2019Week of November 4, 2019 – Third Quarter 2019 Financial Results
02 Mar 2020Week of March 2, 2020 – Full Year 2019 Financial Results
View all

Featured Presentation

08 Mar 2019
ObsEva Short Report 2018 PDF
11 Jan 2019
ObsEva Investor Presentation - January 2019 PDF
05 Mar 2019
Annual Report 2018 PDF
08 Nov 2018
Q3 Report 2018 PDF
08 Aug 2018
Half-Year Report 2018 PDF
16 May 2018
Q1 Report 2018 PDF
16 Apr 2018
Annual Report 2017 PDF
14 Nov 2017
Q3 Report 2017  PDF
16 Aug 2017
Q2 Report 2017  PDF
18 May 2017
Q1 Report 2017  PDF
21 Apr 2017
Annual Report 2016 PDF

Stock Information

For investor relations, please contact:
IR@obseva.ch